Mutation M157R of Keratin 9 in a Chinese Family with Epidermolytic Palmoplantar Keratoderma
Jianhua Zhao,Zhenghua Zhang,Zhenmin Niu,Leihong Xiang,X Ye,Wei Huang,Zheng Zhang
DOI: https://doi.org/10.1111/j.1365-4632.2008.03441.x
2008-01-01
International Journal of Dermatology
Abstract:with paraneoplastic pemphigus. Br J Dermatol 2005; 153 : 558–564. 3 Sahadevan K, Banerjee A, Wight R. Follicular dendritic cell sarcoma of a cervical lymph node: case report and review of the literature. Ear Nose Throat J 2004; 83 : 848–849. 4 Chan JK, Tsang WY, Ng CS. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline vascular Castleman’s disease. Am J Surg Pathol 1994; 18 : 517–525. 5 Chan AC, Chan KW, Chan JK, et al . Development of follicular dendritic cell sarcoma in hyaline–vascular Castleman’s disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology 2001; 38: 510–518. 6 Wang L, Bu D, Yang Y, et al. Castleman’s tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 2004; 363: 525–531. 7 Barnadas M, Roe E, Brunet S, et al. Therapy of paraneoplastic pemphigus with rituximab: a case report and review of the literature. J Eur Acad Dermatol Venereol 2006; 20: 69–74. 8 Rossum MM, Verhaegen NT, Jonkman MF, et al. Follicular non-Hodgkin’s lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities. Leuk Lymphoma 2004; 45: 2327–2332. 9 El Tal AK, Posner MR, Spigelman Z, et al. Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2006; 55: 449– 459. 10 Cummins DL, Mimouni D, Tzu J, et al. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol 2007; 56: 53–159.